EUVIMEDEUVIMED entdecken
Fallbericht

Primary Cutaneous Spindle Cell Sarcoma With FN1::FGFR1 Fusion

Ahmed Shah, Ying-Chun Lo, Jorge Torres-Mora

Journal of Cutaneous Pathology · 2025

DOI: 10.1111/cup.14794 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2025. Verfasst von Ahmed Shah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Skin Neoplasms, Oncogene Proteins, Fusion, Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a case of a primary cutaneous spindle cell sarcoma (SCS) with FN1 :: FGFR1 fusion. The tumor lacked the typical histologic and immunohistochemical features associated with other FN1 ‐rearranged neoplasms, such as phosphaturic mesenchymal tumors (PMT) and calcified chondroid mesenchymal neoplasms (CCMN). Unlike PMTs, which often feature a cartilaginous matrix and are associated with tumor‐induced osteomalacia (TIO), the present case lacked these characteristics and did not show FGF23 mRNA expression. Immunohistochemically, the tumor cells showed patchy staining for CD34 but were negative for markers such as ERG, desmin, S100, and pan‐TRK. The fusion event in this case involves the loss of the FGFR1 Ig1 (D1) domain, a mechanism proposed to drive oncogenesis by releasing FGFR1 from autoinhibition. Despite the preservation of other FGFR1 domains, no evidence of FGF23 signaling was detected, and the patient had no clinical history of TIO. This case underscores the complexity of oncogenesis in FN1 :: FGFR1 ‐rearranged neoplasms, a form of “promiscuous” gene fusion, where similar fusions lead to diverse tumor phenotypes. It emphasizes the importance of incorporating molecular testing in diagnosing spindle cell sarcomas, particularly those occurring in acral sites, to identify this underrecognized entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 1Skin NeoplasmsOncogene Proteins, FusionSarcomaFibronectinsHumansFibroblast Growth Factor-23MaleFemaleMiddle AgedGene Fusion

Stichwörter der Autor:innen

FN1::FGFR1 fusionFN1‐rearranged tumorscutaneous sarcomas

Substanzen

Receptor, Fibroblast Growth Factor, Type 1FGFR1 protein, humanFN1 protein, humanFibroblast Growth Factor-23Oncogene Proteins, FusionFGF23 protein, humanFibronectins

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Zitieren

APA

Shah, A., Lo, Y. C., & Torres-Mora, J. (2025). Primary Cutaneous Spindle Cell Sarcoma With FN1::FGFR1 Fusion. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14794

Vancouver

Shah A, Lo YC, Torres-Mora J. Primary Cutaneous Spindle Cell Sarcoma With FN1::FGFR1 Fusion. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14794

BibTeX
@article{Shah2025,
  author = {Shah, Ahmed and Lo, Ying-Chun and Torres-Mora, Jorge},
  title = {Primary Cutaneous Spindle Cell Sarcoma With FN1::FGFR1 Fusion},
  journal = {Journal of Cutaneous Pathology},
  year = {2025},
  doi = {10.1111/cup.14794}
}
Kostenlos starten →